Get the Stockscreener App
0.00
100.00%
-0.103
After Hours:
.11
0.11
+
Applied Therapeutics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
See More
Previous Close:
$0.103
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$14.86M
Revenue:
-
Net Income/Loss:
$-119.76M
P/E Ratio:
0.00
EPS:
-1.35
Net Cash Flow:
$-55.17M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$1.50
Applied Therapeutics Inc Stock (APLT) Company Profile
Name
Applied Therapeutics Inc
Sector
Industry
Phone
212-220-9226
Address
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Compare APLT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.00 | 14.86M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.69 | 117.06B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
759.86 | 80.87B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
717.80 | 45.06B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.66 | 42.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
301.12 | 32.42B | 5.36B | 287.73M | 924.18M | 2.5229 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-03-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-23-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-02-24 | Downgrade | UBS | Buy → Neutral |
| Nov-29-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-31-24 | Initiated | William Blair | Outperform |
| Mar-26-24 | Initiated | RBC Capital Mkts | Outperform |
| Feb-22-24 | Initiated | Leerink Partners | Outperform |
| Jan-04-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Aug-27-21 | Downgrade | Goldman | Neutral → Sell |
| Jun-25-21 | Resumed | Goldman | Neutral |
| Oct-08-20 | Initiated | Truist | Buy |
| Apr-22-20 | Initiated | Goldman | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jun-10-19 | Initiated | Citigroup | Buy |
| Jun-10-19 | Initiated | Cowen | Outperform |
| Jun-10-19 | Initiated | Robert W. Baird | Outperform |
View All
Applied Therapeutics Inc Stock (APLT) Latest News
APLT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Momentum Shift: How does Applied Therapeutics Inc score in quality rankings2025 Market Overview & Growth Oriented Trading Recommendations - baoquankhu1.vn
Should you buy the dip on Applied Therapeutics Inc.Watch List & High Accuracy Buy Signal Tips - mfd.ru
IPO Launch: Can Applied Therapeutics Inc keep up with sector leadersDollar Strength & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Can Applied Therapeutics Inc. keep up with sector leadersMarket Sentiment Review & Smart Allocation Stock Reports - mfd.ru
[15-12G] Applied Therapeutics, Inc. SEC Filing - Stock Titan
Will Applied Therapeutics Inc. stock benefit from sector rotationJuly 2025 Intraday Action & Community Shared Stock Ideas - mfd.ru
Highs Report: What are Applied Therapeutics Incs recent SEC filings showing2025 Price Action Summary & Technical Pattern Based Signals - baoquankhu1.vn
Aug Mood: Is VivoSim Labs Inc benefiting from innovation trendsQuarterly Market Summary & Pattern Based Trade Signal System - baoquankhu1.vn
Cycle Group acquires Applied Therapeutics to expand rare disease portfolio By Investing.com - Investing.com Nigeria
Applied Therapeutics completes merger and Nasdaq delisting move - The Globe and Mail
Cycle Group Holdings Limited completed the acquisition of Applied Therapeutics, Inc.. - marketscreener.com
Applied Therapeutics completes merger with Cycle Group Holdings, delists from Nasdaq - Investing.com
Cycle Group Holdings Acquires Applied Therapeutics - Contract Pharma
Cycle Group acquires Applied Therapeutics to expand rare disease portfolio - Investing.com
Applied Therapeutics Announces Board and Management Changes Following Merger - TradingView
Applied Therapeutics, Inc. Announces Management Changes - marketscreener.com
Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics - Business Wire
Cycle Pharmaceuticals Acquires Applied Therapeutics - National Today
Sectors Review: Will Applied Therapeutics Inc benefit from seasonalityGap Up & Expert Curated Trade Ideas - baoquankhu1.vn
Earnings Recap: Can EFCPRA reach all time highs this yearRate Cut & Smart Swing Trading Techniques - baoquankhu1.vn
APLT Stock Price, Forecast & Analysis | APPLIED THERAPEUTICS INC (NASDAQ:APLT) - ChartMill
Published on: 2026-02-01 03:43:48 - baoquankhu1.vn
Retail Traders Cheer Applied Therapeutics Data On Rare Nerve Disease Drug - MSN
Cycle Pharmaceuticals Announces Further Extension of Applied Therapeutics Tender Offer - marketscreener.com
Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer - Business Wire
Cycle extends tender offer deadline for Applied Therapeutics acquisition By Investing.com - Investing.com Nigeria
What chart patterns are forming on Applied Therapeutics Inc.Layoff News & Detailed Earnings Play Alerts - mfd.ru
Applied Therapeutics (APLT) Updates on Cycle Group's Acquisition Offer - GuruFocus
Cycle extends tender offer deadline for Applied Therapeutics acquisition - Investing.com
Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension - The Manila Times
Applied Therapeutics (NASDAQ: APLT) extends tender offer, 44% of shares tendered - Stock Titan
Applied Therapeutics Announces Extension of Tender Offer by Cycle Group Holdings for Acquisition | APLT Stock News - Quiver Quantitative
Applied Therapeutics Shares Letter to Stockholders - GlobeNewswire
Applied Therapeutics warns: tender now or risk getting nothing - stocktitan.net
Acquisition of Applied Therapeutics Nears Finalization - AD HOC NEWS
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) - GuruFocus
Applied Therapeutics chief medical officer sells $52,507 in stock - MSN
Will Applied Therapeutics Inc. stock see insider buyingSector Performance Drivers & Free Take Advantage Of Momentum - Bollywood Helpline
Insider Trends: What are Applied Therapeutics Incs recent SEC filings showingWeekly Stock Summary & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Why RF Industries Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket - Benzinga
Trend Review: Why Applied Therapeutics Inc stock is rated strong buy2025 Investor Takeaways & Accurate Trade Setup Notifications - Bộ Nội Vụ
Applied Therapeutics (APLT) Upgraded to Buy: Here's Why - MSN
Why Applied Therapeutics Inc. stock attracts global investorsWeekly Loss Report & AI Forecast Swing Trade Picks - Улправда
Support Test: Why Applied Therapeutics Inc. stock attracts global investorsTrend Reversal & Low Drawdown Momentum Ideas - Улправда
Leerink Partners downgrades Applied Therapeutics (APLT) - MSN
Bond Watch: Will Applied Therapeutics Inc. stock continue dividend increasesDip Buying & Daily Technical Forecast Reports - Улправда
Can Applied Therapeutics Inc. stock beat analyst upgradesJuly 2025 Selloffs & AI Enhanced Trading Signals - Улправда
Will Applied Therapeutics Inc. stock continue dividend increasesWeekly Market Report & Free Technical Pattern Based Buy Signals - Улправда
Aug Analyst Calls: Will Applied Therapeutics Inc. stock see insider buyingJuly 2025 Fed Impact & Low Risk Entry Point Guides - Улправда
Why Applied Therapeutics Inc. (2UV) stock is upgraded to buyTrade Analysis Report & Weekly Watchlist of Top Performers - Улправда
Applied Therapeutics Inc Stock (APLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
2.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):